|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Suzuki R, Yamamoto E, Nojima M, Maruyama
R, Yamano HO, Yoshikawa K, Kimura T, Harada T, Ashida M, Niinuma T,
et al: Aberrant methylation of microRNA-34b/c is a predictive
marker of metachronous gastric cancer risk. J Gastroenterol.
49:1135–1144. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bria E, De Manzoni G, Beghelli S,
Tomezzoli A, Barbi S, Di Gregorio C, Scardoni M, Amato E, Frizziero
M, Sperduti I, et al: A clinical-biological risk stratification
model for resected gastric cancer: Prognostic impact of Her2, Fhit,
and APC expression status. Ann Oncol. 24:693–701. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kraljevic Pavelic S, Sedic M, Bosnjak H,
Spaventi S and Pavelic K: Metastasis: New perspectives on an old
problem. Mol Cancer. 10:222011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Savagner P, Boyer B, Valles AM, Jouanneau
J and Thiery JP: Modulations of the epithelial phenotype during
embryogenesis and cancer progression. Cancer Treat Res. 71:229–249.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tam WL and Weinberg RA: The epigenetics of
epithelial-mesenchymal plasticity in cancer. Nat Med. 19:1438–1449.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu J, Chen X, Ward T, Pegram M and Shen
K: Combined niclosamide with cisplatin inhibits
epithelial-mesenchymal transition and tumor growth in
cisplatin-resistant triple-negative breast cancer. Tumour Biol.
37:9825–9835. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Luo M, Hou L, Li J, Shao S, Huang S, Meng
D, Liu L, Feng L, Xia P, Qin T and Zhao X: VEGF/NRP-1axis promotes
progression of breast cancer via enhancement of
epithelial-mesenchymal transition and activation of NF-κB and
β-catenin. Cancer Lett. 373:1–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma J, Zhao J, Lu J, Wang P, Feng H, Zong
Y, Ou B, Zheng M and Lu A: Cadherin-12 enhances proliferation in
colorectal cancer cells and increases progression by promoting EMT.
Tumour Biol. 37:9077–9088. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bruyere F, Namdarian B, Corcoran NM,
Pedersen J, Ockrim J, Voelzke BB, Mete U, Costello AJ and Hovens
CM: Snail expression is an independent predictor of tumor
recurrence in superficial bladder cancers. Urol Oncol. 28:591–596.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chiu KY, Wu CC, Chia CH, Hsu SL and Tzeng
YM: Inhibition of growth, migration and invasion of human bladder
cancer cells by antrocin, a sesquiterpene lactone isolated from
Antrodia cinnamomea, and its molecular mechanisms. Cancer Lett.
373:174–184. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee SO, Yang X, Duan S, Tsai Y, Strojny
LR, Keng P and Chen Y: IL-6 promotes growth and
epithelial-mesenchymal transition of CD133+ cells of non-small cell
lung cancer. Oncotarget. 7:6626–6638. 2016.PubMed/NCBI
|
|
15
|
Huang L, Wu RL and Xu AM:
Epithelial-mesenchymal transition in gastric cancer. Am J Transl
Res. 7:2141–2158. 2015.PubMed/NCBI
|
|
16
|
Parekh AB: Store-operated CRAC channels:
Function in health and disease. Nat Rev Drug Discov. 9:399–410.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen YF, Chiu WT, Chen YT, Lin PY, Huang
HJ, Chou CY, Chang HC, Tang MJ and Shen MR: Calcium store sensor
stromal-interaction molecule 1-dependent signaling plays an
important role in cervical cancer growth, migration, and
angiogenesis. Proc Natl Acad Sci USA. 108:15225–15230. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang S, Zhang JJ and Huang XY: Orai1 and
STIM1 are critical for breast tumor cell migration and metastasis.
Cancer Cell. 15:124–134. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu J, Qin K, Zhang Y, Gong J, Li N, Lv D,
Xiang R and Tan X: Downregulation of transcription factor Oct4
induces an epithelial-to-mesenchymal transition via enhancement of
Ca2+ influx in breast cancer cells. Biochem Biophys Res Commun.
411:786–791. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Z, Liu X, Feng B, Liu N, Wu Q, Han
Y, Nie Y, Wu K, Shi Y and Fan D: STIM1, a direct target of
microRNA-185, promotes tumor metastasis and is associated with poor
prognosis in colorectal cancer. Oncogene. 34:4808–4820. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Casas-Rua V, Tomas-Martin P,
Lopez-Guerrero AM, Alvarez IS, Pozo-Guisado E and Martin-Romero FJ:
STIM1 phosphorylation triggered by epidermal growth factor mediates
cell migration. Biochim Biophys Acta. 1853:233–243. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Edge S, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Handbook. Chicago:
Springer-Verlag New York; 2010
|
|
23
|
World Health Organization Classification
of Tumours: Pathology and genetics of tumours of the digestive
system. Lyon: IARC Press; 2000
|
|
24
|
Wang JY, Sun J, Huang MY, Wang YS, Hou MF,
Sun Y, He H, Krishna N, Chiu SJ, Lin S, et al: STIM1 overexpression
promotes colorectal cancer progression, cell motility and COX-2
expression. Oncogene. 34:4358–4367. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chaw SY, Majeed AA, Dalley AJ, Chan A,
Stein S and Farah CS: Epithelial to mesenchymal transition (EMT)
biomarkers-E-cadherin, beta-catenin, APC and Vimentin-in oral
squamous cell carcinogenesis and transformation. Oral Oncol.
48:997–1006. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ouadid-Ahidouch H, Dhennin-Duthille I,
Gautier M, Sevestre H and Ahidouch A: TRP channels: Diagnostic
markers and therapeutic targets for breast cancer? Trends Mol Med.
19:117–124. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Prevarskaya N, Skryma R and Shuba Y:
Calcium in tumour metastasis: New roles for known actors. Nat Rev
Cancer. 11:609–618. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bergmeier W, Weidinger C, Zee I and Feske
S: Emerging roles of store-operated Ca2+ entry through
STIM and ORAI proteins in immunity, hemostasis and cancer. Channels
(Austin). 7:379–391. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu H, Hughes JD, Rollins S, Chen B and
Perkins E: Calcium entry via ORAI1 regulates glioblastoma cell
proliferation and apoptosis. Exp Mol Pathol. 91:753–760. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wong HS and Chang WC: Correlation of
clinical features and genetic profiles of stromal interaction
molecule 1 (STIM1) in colorectal cancers. Oncotarget.
6:42169–42182. 2015.PubMed/NCBI
|
|
31
|
Li Y, Guo B, Xie Q, Ye D, Zhang D, Zhu Y,
Chen H and Zhu B: STIM1 Mediates Hypoxia-Driven
Hepatocarcinogenesis via Interaction with HIF-1. Cell Rep.
12:388–395. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sabbioni S, Barbanti-Brodano G, Croce CM
and Negrini M: GOK: A gene at 11p15 involved in rhabdomyosarcoma
and rhabdoid tumor development. Cancer Res. 57:4493–4497.
1997.PubMed/NCBI
|
|
33
|
Sabbioni S, Veronese A, Trubia M,
Taramelli R, Barbanti-Brodano G, Croce CM and Negrini M: Exon
structure and promoter identification of STIM1 (alias GOK), a human
gene causing growth arrest of the human tumor cell lines G401 and
RD. Cytogenet Cell Genet. 86:214–218. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Suyama E, Wadhwa R, Kaur K, Miyagishi M,
Kaul SC, Kawasaki H and Taira K: Identification of
metastasis-related genes in a mouse model using a library of
randomized ribozymes. J Biol Chem. 279:38083–38086. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Weidinger C, Shaw PJ and Feske S: STIM1
and STIM2-mediated Ca(2+) influx regulates antitumour immunity by
CD8(+) T cells. EMBO Mol Med. 5:1311–1321. 2013. View Article : Google Scholar : PubMed/NCBI
|
